Canopy Growth (CGC) Capital Expenditures (2019 - 2026)
Canopy Growth (CGC) posted Capital Expenditures of $3.1 million for Q4 2025, up 229.65% sequentially from $942556.5 in Q2 2025, and up 257.24% YoY from $869756.7 in Q4 2024.
Canopy Growth (CGC) Capital Expenditures (2019 - 2026) Analysis & Trends
Canopy Growth has reported Capital Expenditures for 7 years, with the latest figure at $3.1 million in Q4 2025.
- Quarterly Capital Expenditures rose 257.24% year-over-year to $3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.8 million (up 17.17% YoY) and the FY2026 annual result came in at $3.9 million, down 48.39% from the prior year.
- Capital Expenditures grew to $3.1 million in Q4 2025 per CGC's latest filing, from $942556.5 in the prior quarter.
- Over five years, Capital Expenditures peaked at $102.9 million in Q1 2021 and troughed at $50526.4 in Q1 2022.
- A 5-year average of $8.4 million and a median of $1.5 million in 2022 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures plunged 99.95% in 2022, then jumped 4201.17% in 2023.
- Over 5 years, Capital Expenditures stood at $763189.3 in 2021, then jumped by 80.32% to $1.4 million in 2022, then slumped by 69.9% to $414278.0 in 2023, then soared by 109.95% to $869756.7 in 2024, then jumped by 257.24% to $3.1 million in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $3.1 million, $942556.5, and $869756.7 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Canopy Growth | 449.71 Mn | 202.70 Mn | 16.08 Mn | 532,795.93 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 532,795.93 |
| Jun 30, 2026 | 532,795.93 |
| Dec 31, 2025 | 3.11 Mn |
| Dec 31, 2025 | 3.11 Mn |
| Jun 30, 2025 | 942,556.52 |
| Jun 30, 2025 | 942,556.52 |
| Dec 31, 2024 | 869,756.71 |
| Dec 31, 2024 | 869,756.71 |
| Sep 30, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 184,786.19 |
| Mar 31, 2024 | 184,786.19 |
| Dec 31, 2023 | 414,278.04 |
| Dec 31, 2023 | 414,278.04 |
| Sep 30, 2023 | 514,692.02 |
| Sep 30, 2023 | 514,692.02 |
| Jun 30, 2023 | 1.45 Mn |
| Jun 30, 2023 | 1.45 Mn |